Zwaan CM - Search Results

1

Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).

Whitlock JA, Malvar J, Dalla-Pozza L, Goldberg JM, Silverman LB, Ziegler DS, Attarbaschi A, Brown PA, Gardner RA, Gaynon PS, Hutchinson R, Huynh VT, Jeha S, Marcus L, Messinger Y, Schultz KR, Cassar J, Locatelli F, Zwaan CM, Wood BL, Sposto R, Gore L. Whitlock JA, et al. Among authors: zwaan cm. Pediatr Blood Cancer. 2022 Nov;69(11):e29901. doi: 10.1002/pbc.29901. Epub 2022 Aug 21. Pediatr Blood Cancer. 2022. PMID: 35989458

2

Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.

Zwaan CM, Kaspers GJ, Pieters R, Ramakers-Van Woerden NL, den Boer ML, Wünsche R, Rottier MM, Hählen K, van Wering ER, Janka-Schaub GE, Creutzig U, Veerman AJ. Zwaan CM, et al. Blood. 2000 Oct 15;96(8):2879-86. Blood. 2000. PMID: 11023525 Free article.

3

Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.

Zwaan CM, Kaspers GJ, Pieters R, Hählen K, Janka-Schaub GE, van Zantwijk CH, Huismans DR, de Vries E, Rots MG, Peters GJ, Jansen G, Creutzig U, Veerman AJ. Zwaan CM, et al. Blood. 2002 Jan 1;99(1):245-51. doi: 10.1182/blood.v99.1.245. Blood. 2002. PMID: 11756178 Free article.

4

Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities.

Zwaan CM, Kaspers GJ, Pieters R, Hählen K, Huismans DR, Zimmermann M, Harbott J, Slater RM, Creutzig U, Veerman AJ. Zwaan CM, et al. Blood. 2002 Nov 1;100(9):3352-60. doi: 10.1182/blood.V100.9.3352. Blood. 2002. PMID: 12384437 Free article.

5

Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience.

Slats AM, Egeler RM, van der Does-van den Berg A, Korbijn C, Hählen K, Kamps WA, Veerman AJ, Zwaan CM. Slats AM, et al. Among authors: zwaan cm. Leukemia. 2005 Apr;19(4):537-44. doi: 10.1038/sj.leu.2403665. Leukemia. 2005. PMID: 15690069

6

Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): single-agent therapeutic window study in relapsed AML.

Kaspers GJ, Reinhardt D, Fleischhack G, Armendariz H, Stark B, Zwaan CM, Zimmermann M, Creutzig U. Kaspers GJ, et al. Among authors: zwaan cm. Pediatr Blood Cancer. 2006 Oct 15;47(5):539-42. doi: 10.1002/pbc.20727. Pediatr Blood Cancer. 2006. PMID: 16358301 Clinical Trial.

7

Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.

Hollink IH, van den Heuvel-Eibrink MM, Zimmermann M, Balgobind BV, Arentsen-Peters ST, Alders M, Willasch A, Kaspers GJ, Trka J, Baruchel A, de Graaf SS, Creutzig U, Pieters R, Reinhardt D, Zwaan CM. Hollink IH, et al. Among authors: zwaan cm. Blood. 2009 Jun 4;113(23):5951-60. doi: 10.1182/blood-2008-09-177949. Epub 2009 Jan 26. Blood. 2009. PMID: 19171881 Free article.

8

Cushing syndrome as a presenting symptom of renal tumors in children.

Segers H, van der Heyden JC, van den Akker EL, de Krijger RR, Zwaan CM, van den Heuvel-Eibrink MM. Segers H, et al. Among authors: zwaan cm. Pediatr Blood Cancer. 2009 Aug;53(2):211-3. doi: 10.1002/pbc.22021. Pediatr Blood Cancer. 2009. PMID: 19353619

9

Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference.

Horton TM, Sposto R, Brown P, Reynolds CP, Hunger SP, Winick NJ, Raetz EA, Carroll WL, Arceci RJ, Borowitz MJ, Gaynon PS, Gore L, Jeha S, Maurer BJ, Siegel SE, Biondi A, Kearns PR, Narendran A, Silverman LB, Smith MA, Zwaan CM, Whitlock JA; ALLNA 2008 Conference. Horton TM, et al. Among authors: zwaan cm. Pediatr Blood Cancer. 2010 Jul 1;54(7):872-8. doi: 10.1002/pbc.22414. Pediatr Blood Cancer. 2010. PMID: 20127846 Free PMC article.

10

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia.

Buitenkamp TD, Mathôt RA, de Haas V, Pieters R, Zwaan CM. Buitenkamp TD, et al. Among authors: zwaan cm. Haematologica. 2010 Jul;95(7):1106-13. doi: 10.3324/haematol.2009.019778. Epub 2010 Apr 23. Haematologica. 2010. PMID: 20418240 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page